Pontifax Management 4 G.P. (2015) Ltd. - 10%+ Owner at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
KROS on Nasdaq
All Insider Reports
All Insider Reports

Pontifax Management 4 G.P. (2015) Ltd. - trading volume in the past year for Keros Therapeutics, Inc.

Holdings reported by Pontifax Management 4 G.P. (2015) Ltd. for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.0001 par value per share 5,250 $83,055 $15.82 15 Oct 2025 By Ran Nussbaum
Common Stock, $0.0001 par value per share 5,250 $83,055 $15.82 15 Oct 2025 By Tomer Kariv
Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax (Cayman) IV, L.P.
Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax (China) IV, L.P.
Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax (Israel) IV, L.P.
Common Stock, $0.0001 par value per share 0 $0 $17.75 15 Oct 2025 By Pontifax Late Stage Fund, L.P.

Transactions reported by Pontifax Management 4 G.P. (2015) Ltd. for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.